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Editorial on the Research Topic
HLA-G-Mediated Immune Tolerance: Past and New Outlooks
This research topic gathered several researchers who actively base their research and investigations 
on the non-classical HLA-G molecule. HLA-G differs from classical HLA class I molecules since it 
has limited protein variability, can be expressed in several membrane-bound and soluble isoforms 
generated by alternative splicing generating, and modulates immune response. HLA-G expression 
is physiologically restricted to the maternal–fetal interface and to immune privileged adult tissues. 
De novo expression of HLA-G is deleterious when present in tumor cells and in chronically infected 
cells, whereas it is advantageous in autoimmune diseases and after transplantation.
In the present collection of manuscripts, different aspects of the HLA-G biology have been 
discussed including the genetic variability, the relationship between HLA-G and other non-classical 
HLA class I molecules, and the role of HLA-G in promoting tolerance in T-cell-mediated diseases 
and in pregnancy.
In the contest of HLA-G genetics, it is intriguing that the overall HLA-G gene structure was 
preserved during the evolution, and the HLA-G variability has been established before human 
dispersion from Africa. Castelli et al. illustrated that most of the variation sites found in the HLA-G 
coding region are either synonymous or intronic mutations and that the HLA-G promoter region 
presents numerous polymorphic sites.
Regarding the role of HLA-G in maintaining tolerance, Rizzo et al. and Dias et al. delivered a solid 
snap shot on the physiological expression of HLA-G and its role in inducing tolerance in autoim-
munity. The Authors also discussed that the de novo expression of HLA-G, specifically in tumors and 
after chronic infections, has important implication in promoting immune escape. Special attention 
received the association between HLA-G polymorphisms, specifically those present at 3′UTR of the 
gene, protein expression, and functions in healthy and pathological conditions.
HLA-G belongs to the HLA class Ib molecules family that contains HLA-E and HLA-F. Morandi 
and Pistoia summarized, for the first time, the relationship between HLA-G and HLA-E in different 
settings. They concluded that, in physiological conditions, HLA-E expression is strongly associ-
ated with HLA-G and both molecules co-operate in promoting anergy in immune effector cells, 
specifically in NK cells. Conversely, HLA-G/HLA-E interaction in pathological conditions, i.e., in 
autoimmune and inflammatory diseases, may exert divergent or potentially opposite effects. The 
central role mediated by the non-classical HLA class I molecules, HLA-G, HLA-E, and HLA-F, in 
promoting tolerance during pregnancy and preeclampsia has been extensively discussed. Djurisic 
and Hviid indicated that in preeclampsia, HLA-F function is still unknown and that despite HLA-E 
is involved in immune suppression, increased soluble HLA-E levels has not been associated with 
preeclampsia. Conversely, the high expression of HLA-G compared to HLA-E and -F in the placenta, 
and the presence of HLA-G in semen, endometrium, in matured cumulus–oocyte complex, as well 
as the rise in soluble level after conception, imply an important role for HLA-G in early pregnancy. 
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Furthermore, the role of HLA-G in immune regulation and spiral 
artery remodeling highlights its importance and multifaceted 
activities. In line with this view, Gregori et al. proposed that, at the 
fetal/maternal interface, the expression of HLA-G coordinates 
the cross-talk between fetal extravillous trophoblasts (EVTs) 
and maternal decidual and immune cells. Upon blastocyst is 
implantation into the uterine wall, trophoblasts indeed differenti-
ate into EVTs that regulate their cell migration in the decidua, 
support the induction of the pro-angiogenic microenvironment 
necessary for vascular remodeling, inhibit effector innate and 
adaptive immune responses, and promote a tolerogenic loop in 
which resident cells become tolerogenic.
Finally, Rebmann et  al. presented and discussed a new 
and interesting novel aspect in the biology of the HLA-G, the 
HLA-G-bearing extracellular vesicles (EVs). Several cell types 
involved in immune tolerance and tissue remodeling, includ-
ing tumor cells, trophoblasts, and mesenchymal stromal cells, 
secrete HLA-G-bearing EVs. The mechanisms underlying the 
functional consequences of HLA-G-bearing EVs are, thus far, 
little investigated. Nevertheless, HLA-G-bearing EVs represent 
a novel mode of HLA-G delivery within target cells, thereby 
bypassing the interaction between HLA-G and its specific recep-
tors. This new concept opens new perspectives in the modulatory 
activity of HLA-G.
Overall, we gathered a nice compilation of old and new find-
ings on HLA-G, and this research topic highlights the importance 
of this immune-modulatory molecule in healthy and pathologi-
cal conditions and proposes new investigation avenue to better 
define HLA-G biology and potentially identify new therapeutic 
strategies for promoting or dampening tolerance.
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